309 related articles for article (PubMed ID: 35146757)
1. Annexin-A1: The culprit or the solution?
Kelly L; McGrath S; Rodgers L; McCall K; Tulunay Virlan A; Dempsey F; Crichton S; Goodyear CS
Immunology; 2022 May; 166(1):2-16. PubMed ID: 35146757
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1: potential for glucocorticoid sparing in RA.
Yang YH; Morand E; Leech M
Nat Rev Rheumatol; 2013 Oct; 9(10):595-603. PubMed ID: 23958797
[TBL] [Abstract][Full Text] [Related]
3. Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn's Disease.
de Paula-Silva M; da Rocha GHO; Broering MF; Queiroz ML; Sandri S; Loiola RA; Oliani SM; Vieira A; Perretti M; Farsky SHP
Front Immunol; 2021; 12():714138. PubMed ID: 34603288
[TBL] [Abstract][Full Text] [Related]
4. Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling.
Pupjalis D; Goetsch J; Kottas DJ; Gerke V; Rescher U
EMBO Mol Med; 2011 Feb; 3(2):102-14. PubMed ID: 21254404
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system.
Yazid S; Norling LV; Flower RJ
Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):94-100. PubMed ID: 22123264
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 in the brain--undiscovered roles?
Solito E; McArthur S; Christian H; Gavins F; Buckingham JC; Gillies GE
Trends Pharmacol Sci; 2008 Mar; 29(3):135-42. PubMed ID: 18262660
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
[TBL] [Abstract][Full Text] [Related]
8. The annexin 1 receptor(s): is the plot unravelling?
Perretti M
Trends Pharmacol Sci; 2003 Nov; 24(11):574-9. PubMed ID: 14607080
[TBL] [Abstract][Full Text] [Related]
9. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.
Qin C; Yang YH; May L; Gao X; Stewart AG; Tu Y; Woodman OL; Ritchie RH
Pharmacol Ther; 2015 Apr; 148():47-65. PubMed ID: 25460034
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspects.
John CD; Gavins FN; Buss NA; Cover PO; Buckingham JC
Curr Opin Pharmacol; 2008 Dec; 8(6):765-76. PubMed ID: 18845272
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes.
Sawmynaden P; Perretti M
Biochem Biophys Res Commun; 2006 Nov; 349(4):1351-5. PubMed ID: 16973129
[TBL] [Abstract][Full Text] [Related]
14. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.
Perretti M; D'Acquisto F
Nat Rev Immunol; 2009 Jan; 9(1):62-70. PubMed ID: 19104500
[TBL] [Abstract][Full Text] [Related]
15. Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma.
Boudhraa Z; Merle C; Mazzocut D; Chezal JM; Chambon C; Miot-Noirault E; Theisen M; Bouchon B; Degoul F
Arch Dermatol Res; 2014 Dec; 306(10):903-14. PubMed ID: 25362540
[TBL] [Abstract][Full Text] [Related]
16. Annexin A1 Attenuates Neutrophil Migration and IL-6 Expression through Fpr2 in a Mouse Model of Streptococcus suis-Induced Meningitis.
Ni C; Gao S; Zheng Y; Liu P; Zhai Y; Huang W; Jiang H; Lv Q; Kong D; Jiang Y
Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318141
[No Abstract] [Full Text] [Related]
17. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
18. Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.
Vital SA; Senchenkova EY; Ansari J; Gavins FNE
Cells; 2020 Nov; 9(11):. PubMed ID: 33202930
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
[TBL] [Abstract][Full Text] [Related]
20. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature.
Pederzoli-Ribeil M; Maione F; Cooper D; Al-Kashi A; Dalli J; Perretti M; D'Acquisto F
Blood; 2010 Nov; 116(20):4288-96. PubMed ID: 20705760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
